Does Waystar Connect to Veradigm?

On the standard X12 transaction set moving between Veradigm practice management and Waystar's clearinghouse: 837 claims and 835 remittances, 270 and 271 for eligibility, 276 and 277 for claim status, and 278 for authorization requests and responses. That is decades old, well understood, and the reason a clearinghouse integration is one of the more predictable projects on any platform.

Veradigm is unusual in publishing the terms of its developer access. Certified FHIR APIs are available through a free Veradigm Connect open account. The proprietary Unity API runs on paid integrator memberships with published monthly tiers, a certification fee per submission and an annual API call fee for each connected client site. A clearinghouse integration mostly runs on the practice management EDI side rather than on Unity, but where Waystar's newer modules pull scheduling or demographic detail beyond the transactions, they may touch Unity, and Veradigm's per site fee model means that cost exists somewhere in your quote. Ask Waystar which Veradigm interfaces its integration uses and whether any Veradigm fee is passed through.

Veradigm's HL7 v2 interfaces are the other path, and on an ambulatory platform the person who owns them is often a consultant rather than an employee. Name that person in the project plan. FHIR R4 and SMART App Launch, which Veradigm documents for clinical access, are not what a clearinghouse uses and are not relevant to this integration.

Prior authorization is where the architecture is moving. Under the CMS Interoperability and Prior Authorization rule, impacted payers must expose FHIR based authorization APIs on a published timetable. Ask Waystar how its authorization suite will consume those from a Veradigm practice, and when. The CMS prior authorization rule page has the dates.

The figures in the table are Waystar's, without a published methodology, and belong in a business case only after you have asked for the denominators. The denial rate benchmark and the days in A/R benchmark give you a neutral starting point.

What Waystar does not publish is a field level statement of what posts back into Veradigm automatically. Not published. Checked September 2026. Ask for a demonstration of an eligibility response and a remit landing in Veradigm without a human copying them. The revenue cycle automation page sets out what to measure once they do.

• Business associate agreement with Waystar, covering subcontractors, data location, retention and any use of de identified claims data.
• Payer enrolment plan with dates for your top payers; this, not technology, sets the timeline.
• Veradigm interface ownership. Who owns the practice management EDI setup and any HL7 or Unity connections, and whether any Veradigm fee applies.
• Payerpath position. If you currently use Payerpath, what the exit terms are and whether any Veradigm bundle pricing changes when you leave it.
• Automation oversight. For any step Waystar performs automatically, who reviews outcomes and how portal automation failures are reported.
• Contract protections. Given Veradigm's reporting position, described on the Veradigm page, make sure your Waystar contract does not depend on the Veradigm one in ways that trap you if the platform changes hands.

The HIPAA and AI compliance page applies to revenue cycle data as much as to clinical data, and the CMS-0057 provider checklist covers the payer side of authorization.

Pricing first. Waystar prices against claim and transaction volume and publishes nothing. Not published. Checked September 2026. Ask for a schedule by transaction type, the minimum commitment and the renewal uplift cap. Waystar pricing covers what can be established before a quote.

Payerpath second. Veradigm's own clearinghouse is already in the platform, and a practice choosing Waystar is choosing to run an outside clearinghouse against the EHR vendor's own. That can be the right call, particularly for the authorization and denial modules, but ask Veradigm what changes in your support relationship and pricing if you do.

Module maturity third. The clearinghouse core is mature; the authorization automation and denial prediction modules are younger. Ask for Veradigm practices using the specific modules you are buying, not Waystar in general. The prior authorization software comparison shows how Waystar's authorization approach differs from the specialist vendors.

Fourth, the Altera confusion. Waystar's Veradigm page carries the Allscripts name, and a reference practice described as "on Allscripts" might be on Sunrise or TouchWorks, which are Altera products with different interfaces. When you call references, ask which product they run.

• Which Veradigm interfaces does the integration use, and does any Veradigm Unity or per site fee apply?
• Which modules are in the quote, and what is the per transaction rate, minimum and renewal cap?
• What posts back into Veradigm automatically, field by field?
• What is the payer enrolment plan and timetable?
• For authorizations, what share of our volume runs on electronic 278, portal automation and manual work by payer?
• How will the authorization suite use payer FHIR APIs under CMS-0057, and when?
• What happens to our Payerpath arrangement and Veradigm pricing if we move?
• Which two Veradigm EHR practices, not Altera, in our specialty can we call?

For the authorization business case, the prior auth cost calculator puts a number on today's manual work, and prior authorization automation and denial management explain what a good pilot measures.

On Veradigm, revenue cycle is often the best first AI project precisely because the documentation field is thin, and Waystar is a credible way to do it. The decision is still three sided: Waystar, Payerpath, and the specialist authorization vendors, priced against your transaction mix and your payer list, with Veradigm's own corporate position taken into account in the contract terms.

Our vendor selection engagement prices those options on the same basis, confirms posting behaviour on your Veradigm build, checks which of your payers support electronic authorization, and runs the references with the Altera question asked. If you want your current denial and authorization performance measured before any vendor quotes an improvement, the AI readiness audit does that. No commissions from Waystar, Veradigm or anyone else. Book a call.